You are viewing the site in preview mode

Skip to main content

Table 2 Associations between MAP–CPV–PL pressure and AKI incidence in linear spline function and quartile analysis

From: Non-linear associations between renal perfusion pressure indexes and AKI incidence and recovery rate

Linear spline analysis

Crude OR (95% CI)

p

Quartile analysis

Crude OR (95% CI)

p

MAP–CVP–PL (< 55)

0.91 (0.90–0.92)

 < 0.01

Q1 (MAP–CVP–PL > 65)

1.53 (1.34–1.90)

 < 0.01

MAP–CVP–PL (> 55)

1.01 (1.01–1.03)

 < 0.01

Q2 (55 < MAP–CVP–PL < 65)

Ref

 
   

Q3 (45 < MAP–CVP–PL < 55)

1.69 (1.50–1.89)

 < 0.01

   

Q4 (MAP–CVP–PL < 45)

4.21 (3.71–4.78)

 < 0.01

Linear spline analysis

Adjusted OR (95% CI)

p

Quartile analysis

Adjusted OR (95% CI)

p

MAP–CVP–PL (< 55)

0.95 (0.94–0.96)

 < 0.01

Q1 (MAP–CVP–PL > 65)

1.68 (1.33–2.11)

 < 0.01

MAP–CVP–PL (> 55)

1.02 (1.01–1.03)

 < 0.01

Q2 (55 < MAP–CVP–PL < 65)

Ref

 
   

Q3 (45 < MAP–CVP–PL < 55)

1.35 (1.19–1.53)

 < 0.01

   

Q4 (MAP–CVP–PL < 45)

1.94 (1.67–2.25)

 < 0.01

Age

1.01 (1.01–1.02)

 < 0.01

Age

1.01 (1.01–1.02)

 < 0.01

Initial hemoglobin

0.97 (0.95–0.99)

0.01

Initial hemoglobin

0.97 (0.95–0.99)

 < 0.01

Diabetes

1.27 (1.14–1.40)

 < 0.01

Diabetes

1.27 (1.14–1.40)

 < 0.01

Coronary disease

0.78 (0.70–0.86)

 < 0.01

Coronary disease

0.77 (0.69–0.85)

 < 0.01

Vasopressor use

1.06 (0.94–1.19)

0.30

Vasopressor use

1.07 (0.95–1.20)

0.22

Hypertension

0.71 (0.65–0.79)

 < 0.01

Hypertension

0.71 (0.65–0.79)

 < 0.01

Initial SOFA

1.22 (1.20–1.25)

 < 0.01

Initial SOFA

1.23 (1.20–1.25)

 < 0.01

Duration of hypotension

1.02 (1.01–1.03)

 < 0.01

Duration of hypotension

1.02 (1.01–1.03)

 < 0.01

  1. MAP mean artery pressure, CVP central venous pressure, PL plateau pressure, OR odds ratio, CI confidence interval, SOFA sequential organ failure assessment